Agreed. A safe drug but perhaps they have the wrong surrogate endpoint or unrefined measurement technique. Voices of the patients and the advocates, caregivers and clinicians should weigh heavily where it is safe. I do think that Janet Woodcock is trying to make some directional changes along with Dr. Temple but they seem to have an uphill battle where personalities are concerned or maybe other factors.
- Forums
- ASX - By Stock
- Sarepta Rare Disease Advisory Panel Meeting today
Agreed. A safe drug but perhaps they have the wrong surrogate...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $7.5K | 1.5M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
56 | 63055651 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 38008482 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
56 | 63055651 | 0.004 |
47 | 46138652 | 0.003 |
18 | 39784402 | 0.002 |
13 | 92470101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 38008482 | 21 |
0.006 | 34263249 | 13 |
0.007 | 22226649 | 17 |
0.008 | 14399594 | 14 |
0.009 | 6000000 | 5 |
Last trade - 10.00am 12/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |